Skip to content
10-Q

Quarterly Report

TYRA BIOSCIENCES, INC. TYRA

0001193125-26-220645

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 59.47M sh
Shares Diluted Q1 2026 · Mar 31, 2026 61.75M sh
Shares Diluted Q1 2026 · Mar 31, 2025 59.34M sh
Capex Q1 2026 · Mar 31, 2026 $88K
Capex Q1 2026 · Mar 31, 2025 $14K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$32.57M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$25.46M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $84.96M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $77.39M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $100.72M
Stockholders Equity Q1 2026 · Mar 31, 2026 $387.58M
Stockholders Equity Q1 2026 · Dec 31, 2025 $259.18M
Stockholders Equity Q1 2026 · Mar 31, 2025 $323.53M
Stockholders Equity Q1 2026 · Dec 31, 2024 $343.15M
Current Liabilities Q1 2026 · Mar 31, 2026 $19.26M
Current Liabilities Q1 2026 · Dec 31, 2025 $18.09M
Total Liabilities Q1 2026 · Mar 31, 2026 $24.47M
Total Liabilities Q1 2026 · Dec 31, 2025 $23.43M
Current Assets Q1 2026 · Mar 31, 2026 $394.61M
Current Assets Q1 2026 · Dec 31, 2025 $265.45M
Total Assets Q1 2026 · Mar 31, 2026 $412.04M
Total Assets Q1 2026 · Dec 31, 2025 $282.61M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.64
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.47
Eps Basic Q1 2026 · Mar 31, 2026 −$0.64
Eps Basic Q1 2026 · Mar 31, 2025 −$0.47
Rd Expense Q1 2026 · Mar 31, 2026 $33.47M
Rd Expense Q1 2026 · Mar 31, 2025 $24.96M
Net Income Q1 2026 · Mar 31, 2026 −$39.31M
Net Income Q1 2026 · Mar 31, 2025 −$28.15M
Operating Income Q1 2026 · Mar 31, 2026 −$42M
Operating Income Q1 2026 · Mar 31, 2025 −$31.85M